SynBioBeta Speaker
Ekaterine Kortkhonjia
Sr. Director, Partnering
Johnson & Johnson
Eka is a Senior Director of Early Innovation Partnering at Johnson and Johnson. In this role Eka is responsible for identification, diligence and strategic transactions for data science opportunities across therapeutic areas from discovery through commercial execution. Eka joined Johnson and Johnson from Genentech/Roche where she spent over 10 years in various roles, including Pharma Partnering, Biomarker Development and Finance. Eka hold a Ph. D. in Chemistry and Chemical Biology and M. S. in Biophysics.
SynBioBeta 2025 - Session Speaker
Innovation Meets Industry: How Startups Can Collaborate with Big Pharma
For startups in the BioPharma space, partnering with big pharma can be the key to scaling innovation and driving real-world impact. This session will bring together leaders from major pharmaceutical companies and successful startups to explore how to bridge the gap between groundbreaking ideas and industry execution. Learn about the key factors pharma companies look for in potential partners, best practices for collaboration" with "Innovation Meets Industry: How Startups Can Collaborate with Big Pharma"
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Price increases in
16:03:15:43
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
2026
Event Updates